Hemoglobin A1c Testing Devices Market Report 2026 Market Outlook Supported By A Forecast 11.1% CAGR

The Business Research Company

The Business Research Company's Hemoglobin A1c Testing Devices Market Report 2026 Market Outlook Supported By A Forecast 11.1% CAGR

LONDON, GREATER LONDON, UNITED KINGDOM, August 10, 2026 /EINPresswire.com/ -- "The hemoglobin A1c testing devices market has witnessed significant growth recently, driven by the increasing prevalence of diabetes and advancements in monitoring technologies. As more individuals seek effective ways to manage blood sugar levels, this market is positioned for substantial expansion in the coming years. Let’s explore the current market size, key growth factors, and regional trends shaping this industry.

Current Market Size and Expected Growth of the Hemoglobin A1c Testing Devices Market
The market for hemoglobin A1c testing devices has expanded rapidly over recent years and is projected to continue this trend. It is estimated to grow from $2.08 billion in 2025 to $2.32 billion in 2026, representing a compound annual growth rate (CAGR) of 11.7%. This historical growth has been fueled by the increasing number of diabetes cases, wider implementation of routine blood glucose monitoring, enhanced availability of diagnostic labs, growing public awareness about glycemic control, and greater adoption of standardized testing procedures.

Download a free sample of the hemoglobin a1c testing devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9077&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Looking ahead, the market is expected to accelerate, reaching $3.53 billion by 2030 with a CAGR of 11.1%. This surge is driven by rising demand for home-based diabetes monitoring, the integration of AI-powered analytics, expansion of remote patient monitoring services, and an increased focus on personalized diabetes care. Other notable trends include the growing use of point-of-care HbA1c testing devices, the popularity of portable and handheld testers, greater connectivity with digital diabetes management platforms, faster and more accurate testing assays, and an emphasis on patient-centered monitoring solutions.

Understanding Hemoglobin A1c Testing Devices and Their Role
Hemoglobin A1c testing devices measure the amount of glycated hemoglobin in the blood, which forms when glucose binds to hemoglobin. This measurement provides an average blood sugar level over time and is crucial for regular monitoring in diabetes management. These devices help healthcare providers and patients track disease progression, adjust treatments, and prevent complications effectively.

View the full hemoglobin a1c testing devices market report:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Stimulating Growth in the Hemoglobin A1c Testing Devices Market
A primary driver of market growth is the rising incidence of diabetes worldwide. Diabetes is a chronic metabolic condition marked by elevated blood glucose levels, requiring continuous monitoring and management. Hemoglobin A1c testing plays a pivotal role in diagnosing type 2 diabetes, pre-diabetes, and managing the disease over time by offering insights into average glucose control. Such information empowers patients and clinicians to make informed treatment decisions aimed at avoiding severe health complications.

For example, in June 2024, the UK’s National Health Service reported a significant increase in pre-diabetes cases. In 2023, NHS identified more than 549,000 additional individuals in England at risk of developing type 2 diabetes, raising the total number of people with non-diabetic hyperglycemia registered with general practitioners to 3,615,330. This marked a nearly 20% rise from 3,065,825 in 2022, illustrating the growing population that could benefit from HbA1c testing devices. Consequently, this surge in diabetes and pre-diabetes cases is expected to drive strong demand in this market.

Regional Outlook and Fastest Growing Markets in Hemoglobin A1c Testing Devices
In 2025, North America held the largest share of the hemoglobin A1c testing devices market, reflecting the region’s advanced healthcare infrastructure and high diabetes prevalence. However, Asia-Pacific is set to emerge as the fastest-growing market during the forecast period. The comprehensive market analysis spans regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad view of global growth opportunities.

What’s included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X